Xtant Medical Holdings (XTNT) Misses Q3 EPS Views; Boosts FY16 Revenue Outlook

Xtant Medical Holdings (NYSE: XTNT) reported Q3 EPS of ($0.40), $0.32 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $23.1 million versus the consensus estimate of $22.1 million.

GUIDANCE:

Xtant Medical Holdings sees FY2016 revenue of $89-91 million, versus prior guidance of $87-90 million and the consensus of $88 million.

For earnings history and earnings-related data on Xtant Medical Holdings (XTNT) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Endexx Corporation (EDXC) Reports Q1 Loss of $0.01
• Community West Bancshares (CWBC) Tops Q1 EPS by 7c